ATRX and central nervous system cancer: Till now limited studies have been conducted in Indian patients regarding frequency of 1p/19q codeletion, IDH 1 mutation, ATRX deletion and TP53 and further to correlate individual markers signature with response to chemoradiation and impact on overall survival in high grade gliomas.